Trial Profile
A Phase 2,Double-blinded, Double Dummy, Positive Drug, Parallel, Randomised Controlled Multicenter Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Anaprazole (Primary) ; Rabeprazole
- Indications Duodenal ulcer
- Focus Therapeutic Use
- Sponsors Sihuan Pharmaceutical Holdings Group
- 14 Feb 2020 Results published in the Sihuan Pharmaceutical Holdings Group Media Release.
- 14 Feb 2020 Status changed from recruiting to completed, according to an Sihuan Pharmaceutical Holdings Group media release.
- 06 Sep 2018 New trial record